Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $416.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding INBS, Q2 2026
No superinvestor reported holding INBS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Intelligent Bio Solutions Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2023 (view filing) | Oct 4 | 2 days | Towers ChristopherDirector | PPurchase | +9.09K | – | – | +1,150.6%9.88K after | |
| Oct 6, 2023 (view filing) | Oct 4 | 2 days | Towers ChristopherDirector | PPurchase | +18.2K | – | – | –9.09K after | Derivative2 lots |
| Sep 5, 2023 (view filing) | Aug 31-Sep 1 | 5 days | Simeonidis HarryCEO | PPurchaseCommon Stock, par value $0.01 per share | +150 | $1.90 | +$284.5 | +3.7%4.18K after | 2 lots |
| Dec 23, 2022 (view filing)6:06 AM ET | Dec 22 | 1 day | Sakiris Spiro KevinChief Financial Officer | PPurchase | +64.0K | $0.3125 | +$20.0K | –48.0K after | Derivative2 lots |
| Jun 24, 2022 (view filing) | Jun 22 | 2 days | Sakiris Spiro KevinChief Financial Officer | PPurchase | +5.00K | $0.65 | +$3.25K | +11.1%50.2K after | |
| Jun 22, 2022 (view filing) | Jun 17 | 5 days | Sakiris Spiro KevinChiefFinancial Officer | PPurchase | +16.0K | $0.61 | +$9.74K | +54.6%45.2K after | |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Life Science Biosensor Diagnostics Pty LtdOther: Former 10% owner | SSale | −576.0K | $0.51 | −$293.8K | −34.7%1.08M after | |
| Feb 18, 2022 (view filing) | Feb 16 | 2 days | Life Science Biosensor Diagnostics Pty Ltd10% Owner | SSale | −100.0K | $0.63 | −$63.0K | −5.7%1.66M after | |
| Feb 17, 2022 (view filing) | Feb 11-15 | 6 daysLate | Life Science Biosensor Diagnostics Pty Ltd10% Owner | SSale | −300.0K | $0.71 | −$213.0K | −14.6%1.76M after | 3 lots |
| Feb 15, 2022 (view filing) | Feb 10 | 5 daysLate | Life Science Biosensor Diagnostics Pty Ltd10% Owner | SSale | −100.0K | $0.84 | −$84.0K | −4.6%2.06M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Intelligent Bio Solutions Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 141,397 | $324.5K | 0.01% | +11,397+8.8% | Added |
| Geode Capital Management, LLC | 20,840 | $47.8K | 0.00% | −7,769−27.2% | Reduced |
| Vanguard Capital Management LLC | 5,810 | $13.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,735 | $13.2K | 0.00% | +5,363+1,441.7% | Added |
| Vanguard Fiduciary Trust Co | 3,958 | $9.08K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,280 | $7.53K | 0.00% | +2,030+162.4% | Added |
| Advisor Group Holdings, Inc. | 200 | $460 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 142 | $326 | 0.00% | +142 | New |